Mary Ann Liebert, Inc.

Mary Ann Liebert, Inc. is an academic publishing firm established in 1980 by its president, Mary Ann Liebert. The company specializes in publishing peer-reviewed journals, books, and trade magazines focused on subjects like biotechnology, biomedical research, life sciences, clinical medicine, alternative and integrative medicine, surgery, and law. Its main office is located in New Rochelle, New York, USA.

International

English

Media Company

Outlet metrics

Domain Authority

Ranking

Global

#60569

United States

#30965

Business and Consumer Services/Publishing and Printing

#35

Traffic sources

Monthly visitors

Articles

Delivering Specialty Gases for Potential Therapeutic Effect—Ventilator Validation of Safety Is Paramount | Respiratory Care

1 month ago | liebertpub.com | John Davies

Mechanical ventilators are designed to function using 50 pounds per square inch (psi) inputs from 100% medical grade oxygen and medical grade air only. Introducing a different gas into the system (either through a 50 psi input or into the patient circuit) can potentially have a profound effect on the functionality of the ventilator due to differing chemical properties that the particular gas may have.
The Association Between Thyrotropin and Clinically Relevant Depression: A Retrospective Cross-Sectional Study

2 months ago | liebertpub.com | Amanda Bakian |Michael Newman
A Roadmap for Implementation of American Association for Respiratory Care Clinical Practice Guidelines

2 months ago | liebertpub.com | Lynda T Goodfellow |Candice J. Devlin |Rory S. O’Bryan |Hope Williams

In this month’s issue, Devlin and colleagues1 provide a roadmap for community hospitals desiring to implement evidence-based guidelines in their practice. This multidisciplinary team began a quality improvement project to address the increased tracheostomized patient census during COVID-19. The aim was to implement recommendations based on the 2021 American Association for Respiratory Care (AARC) Clinical Practice Guideline (CPG)2 for care of tracheostomized patients in their acute care setting.
Ventilator Liberation Practices in Pediatric Cardiac Critical Care

2 months ago | liebertpub.com | Amy Romer |Candice J. Devlin |Rory S. O’Bryan |Hope Williams

Get full access to this articleView all available purchase options and get full access to this article. References1. Gaies M, Tabbutt S, Schwartz SM, et al. Clinical epidemiology of extubation failure in the pediatric cardiac ICU: a report from the Pediatric Cardiac Critical Care Consortium. Pediatr Crit Care Med. 2015;16(9):837–845. 2. Abu-Sultaneh S, Iyer NP, Fernández A, et al.
HIV-1 DNA Genotypic Drug Resistance Testing Guides Antiretroviral Therapy in Patients with Low-Level Viremia

Jan 14, 2025 | liebertpub.com | Tong Wang |Li Zhong

Information & AuthorsPublished In AIDS Research and Human RetrovirusesHistoryPublished online: 15 January 2025TopicsData AvailabilityThe data collected in this study will be available to external investigators interested in collaboration upon submission and approval of a data analysis plan. Requests for data should be submitted to [email protected]. Authors’ ContributionsT.W., B.C., and L.Z. conceived the idea and supervised this study.
Esophageal Pressure Measurements to Predict Alveolar Recruitment and Overdistension in Patients With ARDS

Jan 10, 2025 | liebertpub.com | Arnaud W Thille

In patients with ARDS, the main objective of ventilatory management is to avoid alveolar collapse at expiration and alveolar overdistention at inspiration.
Choosing the Proper Interface for Positive Airway Pressure Therapy in Subjects With Acute Respiratory Failure

Dec 17, 2024 | liebertpub.com | Ravi Gupta

IntroductionNoninvasive ventilation (NIV) is a major treatment modality in patients with acute respiratory failure (ARF), as well as chronic respiratory failure and sleep-disordered breathing.1–3 Despite significant advances in NIV technology and the experience of medical staffs, the failure rate of NIV in the acute setting remains high, ranging between 18% and 40%.4 The success of NIV therapy depends on the underlying cause of ARF, patient cooperation, and staff experience.
Cardiovascular Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Virologically Suppressed PLWHIV: A Comparative Analysis of CVD Scores

Oct 29, 2024 | liebertpub.com | Arturo Ciccullo

Get full access to this articleView all available purchase options and get full access to this article. References1. McGettrick P, Mallon PWG, Sabin CA. Cardiovascular disease in HIV patients: Recent advances in predicting and managing risk. Expert Rev anti Infect Ther 2020;18(7):677–688;2. Surial B, Chammartin F, Damas J, et al. Swiss HIV Cohort Study. Impact of integrase inhibitors on cardiovascular disease events in people with human immunodeficiency virus starting antiretroviral therapy.
Comparison of the Performance of Commercially Available Quantitative Viral Load Assays Using Clinical Samples from Patients from Regions Where Distinct HIV-1 Subtypes Co-Circulate: Potential Implications for Patient Management | AIDS Research and Human Re

Oct 28, 2024 | liebertpub.com | Ricardo Diaz |Ricardo Díaz

Get full access to this articleView all available purchase options and get full access to this article. References1. Samji H, Cescon A, Hogg RS, et al. North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013;8(12):e81355;2. Lohse N, Obel N. Update of survival for persons with HIV infection in Denmark. Ann Intern Med 2016;165(10):749–750;3.
The CRISPR Journal

Oct 18, 2024 | liebertpub.com | Suchita P. Nety |Fyodor Urnov |Jon Rueda |Lluis Montoliu

The CRISPR JournalEditor-in-Chief: Rodolphe Barrangou, PhDISSN: 2573-1599 Online ISSN: 2573-1602 Published BimonthlyCurrent Volume: 7 Journal Impact Factor: 3.8* *2023 Journal Citation Reports™ (Clarivate, 2024) The only peer-reviewed journal dedicated to the science and applications of gene editing.